With 1000+ market research reports and 1 billion+ data points, Future Market Insights (FMI) serves each and every requirement of the clients operating in the global healthcare, pharmaceuticals, and ...

Nocturnal Polyuria Treatment market players – Allergan, Inc., Ferring Holding SA, Teva Pharmaceutical Industries Ltd., Urigen Pharmaceuticals, Vantia Therapeutics, Astellas Pharma Inc. And Urigen ...

Nocturnal polyuria syndrome is the passage of increased urine during the night, waking the patient up from sleep. The urine output equals more than 20% of the daily total in younger persons and more ...

Noctiva was approved by the Food and Drug Administration (FDA) in March 2017 based on findings from two 12-week, randomized, double-blind, placebo-controlled trials (N=1045) in patients with nocturia ...

US regulators have issued a green light for the first treatment for frequent urination at night due to overproduction of urine, a condition known as nocturnal polyuria. US regulators have issued a ...

Nocturia remains underreported and undertreated, despite its prevalence and association with significant morbidity and mortality Nocturia has multiple aetiologies, including overproduction of urine ...

A blood test for copeptin, a precursor of antidiuretic hormone (ADH, vasopressin), differentiates between "harmless" polydipsia-polyuria and diabetes insipidus more quickly and accurately than a ...

Diabetes type 2 is a chronic condition whereby the threat of high blood sugar levels is ever-present. Blood sugar - the main type of sugar you get from food - supplies the body with energy but it must ...

Nocturia involves waking up during the night to urinate and becomes more common with age. Limiting fluid intake two hours before bed may reduce night bathroom trips. Treating underlying conditions and ...